![]() | |
Clinical data | |
---|---|
Other names | Thiamylal, Thioseconal, Surital |
AHFS/Drugs.com | International Drug Names |
ATCvet code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Eliminationhalf-life | 14.3 h (cats) |
Identifiers | |
| |
CAS Number |
|
PubChemCID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.000.927![]() |
Chemical and physical data | |
Formula | C12H18N2O2S |
Molar mass | 254.35 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Thiamylal (Surital) is abarbiturate derivative invented in the 1950s. It hassedative,anticonvulsant, andhypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction insurgicalanaesthesia[2] or as an anticonvulsant to counteract side effects from other anaesthetics.[3] It is the thiobarbiturate analogue ofsecobarbital.